RenovaCare Provides Update on Clinical Trial for the SkinGun and CellMist System for Wound Healing,

(Symbol: RCAR; developer of patented technologies for the regeneration of skin and other organs and tissues, today provided an update on its clinical trial evaluating the safety and feasibility of …, (Symbol: RCAR; developer of patented technologies for the regeneration of skin and other organs and tissues, today provided an update on its clinical trial evaluating the safety and feasibility of …, Read More

Scroll to Top